# Convelo Therapeutics, Inc. — Form D

Convelo Therapeutics, Inc. of CLEVELAND, OH, a company, filed a Form D exempt-offering notice with the SEC on 2022-12-08. The offering totals $12.0M, of which $10.8M was reported sold. Industry: Other Health Care.

## Offering

- Filed: 2022-12-08
- Form: D
- Accession: 0001724444-22-000004
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $12.0M
- Amount sold: $10.8M
- Remaining: $1.2M
- Minimum investment: $50K
- Investors: 1
- Date of first sale: 2022-12-02
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-466899

## Issuer

- Name: Convelo Therapeutics, Inc.
- CIK: 0001724444
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 11000 CEDAR AVENUE, CLEVELAND, OH, 44106
- Phone: 2166583969

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| Drew Adams | Director | Cleveland, OH |
| Ronald Richard | Director | Cleveland, OH |
| Derrick Rossi | Director | Cleveland, OH |
| Bill Sanford | Director | Manhattan, KS |
| Paul Tesar | Director | Cleveland, OH |
| Derrick Rossi | Executive Officer | Cleveland, OH |
| Steven Landau | Executive Officer | Cleveland, OH |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2017-12-05](https://search.stillhousedata.com/formd/0001724444-17-000001) | D | $15.0M | $2.0M |

## More

- [CIK 1724444 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1724444&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001724444-22-000004.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.